Drug Approval | April 22, 2023
Ajinomoto Bio-Pharma receives FDA approval for high potency fill line
Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line
Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
SÜDPACK is setting standards in terms of both performance and sustainability
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Subscribe To Our Newsletter & Stay Updated
